A technique for removing tumourigenic pluripotent stem cells using rBC2LCN lectin

INTRODUCTION: Tumourigenesis attributed to residual undifferentiated cells in a graft is considered to be a significant issue in cell therapy using human pluripotent stem cells. To ensure the safety of regenerative medicine derived from pluripotent stem cells, residual undifferentiated cells must be...

Descripción completa

Detalles Bibliográficos
Autores principales: Haramoto, Yoshikazu, Onuma, Yasuko, Mawaribuchi, Shuuji, Nakajima, Yoshiro, Aiki, Yasuhiko, Higuchi, Kumiko, Shimizu, Madoka, Tateno, Hiroaki, Hirabayashi, Jun, Ito, Yuzuru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society for Regenerative Medicine 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240284/
https://www.ncbi.nlm.nih.gov/pubmed/32462059
http://dx.doi.org/10.1016/j.reth.2020.03.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240284/
https://www.ncbi.nlm.nih.gov/pubmed/32462059
http://dx.doi.org/10.1016/j.reth.2020.03.017

Ejemplares similares